BlueWillow Biologics, Inc.

Associate Sponsor

BlueWillow Biologics^® is a clinical-stage company that has developed a best-in-class, intranasal adjuvant and antigen/allergen delivery platform technology enabling intranasal vaccines and immunotherapies. The platform has demonstrated excellent safety in three human clinical trials. The adjuvant elicits a balanced and robust mucosal, systemic and cellular immune response and is compatible with a broad range of antigens. When combined with food proteins (e.g. peanut), the platform takes advantage of its inherent Th1-biased immunogenicity to treat food allergies.